158 related articles for article (PubMed ID: 4023401)
1. Patterns of cerebral glucose utilization in depression, multiple infarct dementia, and Alzheimer's disease.
Kuhl DE; Metter EJ; Riege WH
Res Publ Assoc Res Nerv Ment Dis; 1985; 63():211-26. PubMed ID: 4023401
[TBL] [Abstract][Full Text] [Related]
2. Characteristics of cerebral glucose utilization in dementia.
Matsuzawa T; Matsui H; Meguro K; Ueda M; Yamada K; Yamaguchi T; Itoh M; Hatazawa J; Kinomura S
Sci Rep Res Inst Tohoku Univ Med; 1990 Dec; 37(1-4):11-21. PubMed ID: 2103655
[TBL] [Abstract][Full Text] [Related]
3. Imaging local brain function with emission computed tomography.
Kuhl DE
Radiology; 1984 Mar; 150(3):625-31. PubMed ID: 6607481
[TBL] [Abstract][Full Text] [Related]
4. Cerebral metabolic differences in Parkinson's and Alzheimer's diseases matched for dementia severity.
Vander Borght T; Minoshima S; Giordani B; Foster NL; Frey KA; Berent S; Albin RL; Koeppe RA; Kuhl DE
J Nucl Med; 1997 May; 38(5):797-802. PubMed ID: 9170449
[TBL] [Abstract][Full Text] [Related]
5. The fluorodeoxyglucose 18F scan in Alzheimer's disease and multi-infarct dementia.
Benson DF; Kuhl DE; Hawkins RA; Phelps ME; Cummings JL; Tsai SY
Arch Neurol; 1983 Nov; 40(12):711-4. PubMed ID: 6605139
[TBL] [Abstract][Full Text] [Related]
6. Patterns of local cerebral glucose utilization determined in Parkinson's disease by the [18F]fluorodeoxyglucose method.
Kuhl DE; Metter EJ; Riege WH
Ann Neurol; 1984 May; 15(5):419-24. PubMed ID: 6610384
[TBL] [Abstract][Full Text] [Related]
7. Diminished glucose transport and phosphorylation in Alzheimer's disease determined by dynamic FDG-PET.
Piert M; Koeppe RA; Giordani B; Berent S; Kuhl DE
J Nucl Med; 1996 Feb; 37(2):201-8. PubMed ID: 8667045
[TBL] [Abstract][Full Text] [Related]
8. Cerebral glucose metabolism in patients with frontotemporal dementia.
Ishii K; Sakamoto S; Sasaki M; Kitagaki H; Yamaji S; Hashimoto M; Imamura T; Shimomura T; Hirono N; Mori E
J Nucl Med; 1998 Nov; 39(11):1875-8. PubMed ID: 9829574
[TBL] [Abstract][Full Text] [Related]
9. Lower brain 18F-fluorodeoxyglucose uptake but normal 11C-acetoacetate metabolism in mild Alzheimer's disease dementia.
Castellano CA; Nugent S; Paquet N; Tremblay S; Bocti C; Lacombe G; Imbeault H; Turcotte É; Fulop T; Cunnane SC
J Alzheimers Dis; 2015; 43(4):1343-53. PubMed ID: 25147107
[TBL] [Abstract][Full Text] [Related]
10. Longitudinal PET Evaluation of Cerebral Metabolic Decline in Dementia: A Potential Outcome Measure in Alzheimer's Disease Treatment Studies.
Alexander GE; Chen K; Pietrini P; Rapoport SI; Reiman EM
Am J Psychiatry; 2002 May; 159(5):738-45. PubMed ID: 11986126
[TBL] [Abstract][Full Text] [Related]
11. [Cerebral glucose metabolism in dementia (PET-FDG study)].
Hatazawa J; Itoh M; Matsuzawa T
Rinsho Hoshasen; 1989 Oct; 34(11):1343-8. PubMed ID: 2601096
[TBL] [Abstract][Full Text] [Related]
12. Alzheimer's disease: focal cortical changes shown by positron emission tomography.
Foster NL; Chase TN; Fedio P; Patronas NJ; Brooks RA; Di Chiro G
Neurology; 1983 Aug; 33(8):961-5. PubMed ID: 6603596
[TBL] [Abstract][Full Text] [Related]
13. Cortical abnormalities in Alzheimer's disease.
Foster NL; Chase TN; Mansi L; Brooks R; Fedio P; Patronas NJ; Di Chiro G
Ann Neurol; 1984 Dec; 16(6):649-54. PubMed ID: 6335378
[TBL] [Abstract][Full Text] [Related]
14. Local cerebral glucose utilization in symptomatic and presymptomatic Huntington's disease.
Kuhl DE; Markham CH; Metter EJ; Riege WH; Phelps ME; Mazziotta JC
Res Publ Assoc Res Nerv Ment Dis; 1985; 63():199-209. PubMed ID: 3161165
[TBL] [Abstract][Full Text] [Related]
15. Positron emission tomography in patients with clinically diagnosed Alzheimer's disease.
McGeer PL; Kamo H; Harrop R; Li DK; Tuokko H; McGeer EG; Adam MJ; Ammann W; Beattie BL; Calne DB
CMAJ; 1986 Mar; 134(6):597-607. PubMed ID: 3512063
[TBL] [Abstract][Full Text] [Related]
16. Brain glucose metabolism during non-rapid eye movement sleep in major depression. A positron emission tomography study.
Ho AP; Gillin JC; Buchsbaum MS; Wu JC; Abel L; Bunney WE
Arch Gen Psychiatry; 1996 Jul; 53(7):645-52. PubMed ID: 8660131
[TBL] [Abstract][Full Text] [Related]
17. Regional cerebral glucose transport and utilization in Alzheimer's disease.
Friedland RP; Jagust WJ; Huesman RH; Koss E; Knittel B; Mathis CA; Ober BA; Mazoyer BM; Budinger TF
Neurology; 1989 Nov; 39(11):1427-34. PubMed ID: 2812318
[TBL] [Abstract][Full Text] [Related]
18. 18F-2-deoxy-2-fluoro-D-glucose as a tracer in the positron emission tomographic study of senile dementia.
Farkas T; Ferris SH; Wolf AP; De Leon MJ; Christman DR; Reisberg B; Alavi A; Fowler JS; George AE; Reivich M
Am J Psychiatry; 1982 Mar; 139(3):352-3. PubMed ID: 6977276
[No Abstract] [Full Text] [Related]
19. Abnormalities of energy metabolism in Alzheimer's disease studied with PET.
Heiss WD; Szelies B; Kessler J; Herholz K
Ann N Y Acad Sci; 1991; 640():65-71. PubMed ID: 1776760
[TBL] [Abstract][Full Text] [Related]
20. [The comparison of the regional cerebral metabolism rate of glucose in Alzheimer's disease with mild cognitive impairment].
Cao Q; Jiang K; Liu Y; Zhang M; Xiao S; Zuo C; Huang H
Zhonghua Yi Xue Za Zhi; 2002 Dec; 82(23):1613-6. PubMed ID: 12667368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]